SE9901572D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9901572D0 SE9901572D0 SE9901572A SE9901572A SE9901572D0 SE 9901572 D0 SE9901572 D0 SE 9901572D0 SE 9901572 A SE9901572 A SE 9901572A SE 9901572 A SE9901572 A SE 9901572A SE 9901572 D0 SE9901572 D0 SE 9901572D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- solvates
- pharmaceutically acceptable
- new compounds
- carboxypeptidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/09—Diamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (53)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
ARP000102082A AR028826A1 (es) | 1999-05-03 | 2000-04-28 | Compuestos que inhiben carboxipeptidasas, un proceso para su preparacion, una formulacion farmaceutica que los contiene y uso de los mismos para la fabricacion de un medicamento |
ARP000102084A AR023819A1 (es) | 1999-05-03 | 2000-04-28 | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
MYPI20001884A MY126962A (en) | 1999-05-03 | 2000-05-02 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
DE60043297T DE60043297D1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
SK1566-2001A SK15662001A3 (sk) | 1999-05-03 | 2000-05-03 | Nové zlúčeniny |
HU0202379A HUP0202379A3 (en) | 1999-05-03 | 2000-05-03 | New compounds, process for producing them and pharmaceutical compositions containing them |
CZ20013931A CZ20013931A3 (cs) | 1999-05-03 | 2000-05-03 | Nové sloučeniny |
CA002371217A CA2371217A1 (fr) | 1999-05-03 | 2000-05-03 | Formulation pharmaceutique contenant un inhibiteur de la carboxypeptidase u et un inhibitor de thrombine |
AU44472/00A AU763772B2 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
KR1020017014009A KR100725206B1 (ko) | 1999-05-03 | 2000-05-03 | 카르복시펩티다제 u 억제제 및 트롬빈 억제제를 함유하는제약 제제 |
US09/600,659 US6974800B1 (en) | 1999-05-03 | 2000-05-03 | Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor |
PCT/SE2000/000846 WO2000066550A1 (fr) | 1999-05-03 | 2000-05-03 | Nouveaux composes |
EP00925845A EP1181048B1 (fr) | 1999-05-03 | 2000-05-03 | Formulation pharmaceutique contenant un inhibiteur de la carboxypeptidase u et un inhibitor de thrombine |
EEP200100578A EE200100578A (et) | 1999-05-03 | 2000-05-03 | Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat |
PCT/SE2000/000847 WO2000066152A1 (fr) | 1999-05-03 | 2000-05-03 | Formulation pharmaceutique contenant un inhibiteur de la carboxypeptidase u et un inhibitor de thrombine |
TR2001/03151T TR200103151T2 (tr) | 1999-05-03 | 2000-05-03 | Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon. |
JP2000615036A JP2002543148A (ja) | 1999-05-03 | 2000-05-03 | カルボキシペプチダーゼu阻害剤とトロンビン阻害剤とを含有する医薬製剤 |
EP00925844A EP1180099A1 (fr) | 1999-05-03 | 2000-05-03 | Nouveaux composes |
CN00809484A CN1358187A (zh) | 1999-05-03 | 2000-05-03 | 新的化合物 |
CZ20013932A CZ20013932A3 (cs) | 1999-05-03 | 2000-05-03 | Farmaceutický prostředek obsahující inhibitor karboxyperoxidasy U a inhibitor thrombinu |
BR0010255-5A BR0010255A (pt) | 1999-05-03 | 2000-05-03 | Formulação farmacêutica, kit de partes, método para tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da trombina e/ou inibição da carboxipeptidase u são requeridas ou desejadas, e, uso de uma formulação |
ES00925845T ES2335383T3 (es) | 1999-05-03 | 2000-05-03 | Una formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa y un inhibidor de trombina. |
PL356119A PL203505B1 (pl) | 1999-05-03 | 2000-05-03 | Preparat farmaceutyczny zawieraj acy inhibitor karboksypeptydazy U i inhibitor trombiny, zestaw sk ladników i zastosowanie preparatu farmaceutycznego |
HU0201615A HUP0201615A3 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
PL00356140A PL356140A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
IL14595100A IL145951A0 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
MXPA01011044A MXPA01011044A (es) | 1999-05-03 | 2000-05-03 | Formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa u y un inhibidor de trombina.. |
RU2001128158/15A RU2242992C2 (ru) | 1999-05-03 | 2000-05-03 | Фармацевтический препарат, содержащий ингибитор карбоксипептидазы u и ингибитор тромбина |
TR2001/03144T TR200103144T2 (tr) | 1999-05-03 | 2000-05-03 | Yeni bileşikler |
BR0010256-3A BR0010256A (pt) | 1999-05-03 | 2000-05-03 | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, método de tratamento ou profilaxia de condições associadas com a inibição da carboxipeptidase u, kit de partes, e, método de tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da carboxipeptidase u e um mecanismo antitrombótico diferente são necessários |
KR1020017014014A KR20020010631A (ko) | 1999-05-03 | 2000-05-03 | 신규 화합물 |
NZ515063A NZ515063A (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
AU44471/00A AU4447100A (en) | 1999-05-03 | 2000-05-03 | New compounds |
JP2000615381A JP4270759B2 (ja) | 1999-05-03 | 2000-05-03 | 新規化合物 |
CA002371215A CA2371215A1 (fr) | 1999-05-03 | 2000-05-03 | Nouveaux composes |
AT00925845T ATE447964T1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
CNB008071284A CN100518820C (zh) | 1999-05-03 | 2000-05-03 | 含有羧肽酶u抑制剂和凝血酶抑制剂的药物制剂 |
SK1565-2001A SK15652001A3 (sk) | 1999-05-03 | 2000-05-03 | Farmaceutický prípravok obsahujúci inhibítor karboxypeptidázy U a inhibítor trombínu |
IL14595300A IL145953A0 (en) | 1999-05-03 | 2000-05-03 | A new inhibitor of carboxypeptidase u |
US09/600,660 US7354895B1 (en) | 1999-05-03 | 2000-05-03 | Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
EEP200100573A EE200100573A (et) | 1999-05-03 | 2000-05-03 | Uued ühendid, nende valmistamise meetod ning kasutamine |
MXPA01011043A MXPA01011043A (es) | 1999-05-03 | 2000-05-03 | Compuestos novedosos que inhiben las carboxipeptidasas basicas. |
TW089108401A TWI232106B (en) | 1999-05-03 | 2000-05-03 | Pharmaceutical compositions and kits of parts for the treatment of a patient suffering from or susceptible to a condition in which inhibition of thrombin and/or inhibition of carboxypeptidase U are required or desired |
NO20015308A NO20015308L (no) | 1999-05-03 | 2001-10-30 | En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor |
ZA200108967A ZA200108967B (en) | 1999-05-03 | 2001-10-30 | New compounds. |
ZA200108966A ZA200108966B (en) | 1999-05-03 | 2001-10-30 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor. |
IS6140A IS6140A (is) | 1999-05-03 | 2001-11-01 | Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil |
IS6141A IS6141A (is) | 1999-05-03 | 2001-11-01 | Ný efnasambönd |
NO20015374A NO20015374D0 (no) | 1999-05-03 | 2001-11-02 | Nye forbindelser |
HK02104304.1A HK1042493A1 (zh) | 1999-05-03 | 2002-06-06 | 新的化合物 |
HK02104301.4A HK1042442B (zh) | 1999-05-03 | 2002-06-06 | 含有羧肽酶u抑制劑和凝血酶抑制劑的藥物製劑 |
US11/293,060 US7423012B2 (en) | 1999-05-03 | 2005-12-02 | Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9901572D0 true SE9901572D0 (sv) | 1999-05-03 |
Family
ID=20415425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Country Status (23)
Country | Link |
---|---|
US (2) | US7354895B1 (fr) |
EP (1) | EP1180099A1 (fr) |
JP (1) | JP4270759B2 (fr) |
KR (1) | KR20020010631A (fr) |
CN (1) | CN1358187A (fr) |
AR (1) | AR028826A1 (fr) |
AU (1) | AU4447100A (fr) |
BR (1) | BR0010256A (fr) |
CA (1) | CA2371215A1 (fr) |
CZ (1) | CZ20013931A3 (fr) |
EE (1) | EE200100573A (fr) |
HK (1) | HK1042493A1 (fr) |
HU (1) | HUP0202379A3 (fr) |
IL (1) | IL145953A0 (fr) |
IS (1) | IS6141A (fr) |
MX (1) | MXPA01011043A (fr) |
NO (1) | NO20015374D0 (fr) |
PL (1) | PL356140A1 (fr) |
SE (1) | SE9901572D0 (fr) |
SK (1) | SK15662001A3 (fr) |
TR (1) | TR200103144T2 (fr) |
WO (1) | WO2000066550A1 (fr) |
ZA (2) | ZA200108966B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019836A1 (fr) * | 1999-09-14 | 2001-03-22 | Meiji Seika Kaisha, Ltd. | Derives d'acides phosphoniques presentant une activite inhibitrice de carboxypeptidase b |
SI1311488T1 (sl) * | 2000-08-17 | 2010-01-29 | Pfizer Ltd | Substituirani imidazoli kot inhibitorji TAFIA |
SE0103272D0 (sv) | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
CA2472239A1 (fr) | 2002-01-22 | 2003-07-31 | Pfizer Inc. | Acides 3-(imidazolyl)-2-aminopropanoiques servant d'inhibiteurs tafia pour traiter des maladies thrombotiques |
US6713496B2 (en) | 2002-01-22 | 2004-03-30 | Pfizer Inc | 3-(imidazolyl)-2-alkoxypropanoic acids |
CA2472238A1 (fr) * | 2002-01-22 | 2003-07-31 | Pfizer Inc. | Acides 3-(imidazolyl)-2-alkoxypropanoiques servant d'inhibiteurs tafia |
JP4472997B2 (ja) | 2002-03-21 | 2010-06-02 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 血漿カルボキシペプチダーゼbインヒビター |
EP2361910A4 (fr) | 2008-10-29 | 2012-08-01 | Taisho Pharmaceutical Co Ltd | Composé ayant une activité inhibitrice des tafia |
ES2960034T3 (es) * | 2019-02-08 | 2024-02-29 | Astrazeneca Ab | Inhibidores de la arginasa y métodos de uso de los mismos |
CN111110837B (zh) * | 2020-01-06 | 2022-11-25 | 中国人民解放军陆军军医大学 | 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2516307A (en) * | 1949-01-06 | 1950-07-25 | Gen Mills Inc | Vinyl resins plasticized with cyano esters |
US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
US4849414A (en) * | 1986-06-11 | 1989-07-18 | E. R. Squibb & Sons, Inc. | Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors |
FR2610951B1 (fr) * | 1987-02-17 | 1989-05-05 | Aerospatiale | Armature tissee pour materiau composite |
IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
SK74594A3 (en) * | 1991-12-17 | 1995-01-12 | Procter & Gamble Pharma | Treatment for treating of osteoporosis |
US5550119A (en) * | 1995-03-02 | 1996-08-27 | Ciba-Geigy Corporation | Phosphono substituted tetrazole derivatives as ECE inhibitors |
US5672592A (en) * | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
JP3440305B2 (ja) * | 1997-04-02 | 2003-08-25 | 高砂香料工業株式会社 | 7−(n−置換アミノ)−2−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法 |
EA001742B1 (ru) | 1997-02-27 | 2001-08-27 | Американ Цианамид Компани | N-гидрокси-2-(алкил-, арил- или гетероарилсульфанил, -сульфинил или -сульфонил)-3-замещенные алкилов, арилов или гетероариламидов в качестве ингибиторов матриксных металлопротеиназ |
AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
SE9901573D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
WO2001019836A1 (fr) * | 1999-09-14 | 2001-03-22 | Meiji Seika Kaisha, Ltd. | Derives d'acides phosphoniques presentant une activite inhibitrice de carboxypeptidase b |
-
1999
- 1999-05-03 SE SE9901572A patent/SE9901572D0/xx unknown
-
2000
- 2000-04-28 AR ARP000102082A patent/AR028826A1/es not_active Application Discontinuation
- 2000-05-03 EE EEP200100573A patent/EE200100573A/xx unknown
- 2000-05-03 CZ CZ20013931A patent/CZ20013931A3/cs unknown
- 2000-05-03 CN CN00809484A patent/CN1358187A/zh active Pending
- 2000-05-03 EP EP00925844A patent/EP1180099A1/fr not_active Ceased
- 2000-05-03 SK SK1566-2001A patent/SK15662001A3/sk unknown
- 2000-05-03 MX MXPA01011043A patent/MXPA01011043A/es unknown
- 2000-05-03 KR KR1020017014014A patent/KR20020010631A/ko not_active Application Discontinuation
- 2000-05-03 TR TR2001/03144T patent/TR200103144T2/xx unknown
- 2000-05-03 BR BR0010256-3A patent/BR0010256A/pt not_active Application Discontinuation
- 2000-05-03 WO PCT/SE2000/000846 patent/WO2000066550A1/fr not_active Application Discontinuation
- 2000-05-03 PL PL00356140A patent/PL356140A1/xx not_active Application Discontinuation
- 2000-05-03 IL IL14595300A patent/IL145953A0/xx unknown
- 2000-05-03 CA CA002371215A patent/CA2371215A1/fr not_active Abandoned
- 2000-05-03 US US09/600,660 patent/US7354895B1/en not_active Expired - Fee Related
- 2000-05-03 AU AU44471/00A patent/AU4447100A/en not_active Abandoned
- 2000-05-03 JP JP2000615381A patent/JP4270759B2/ja not_active Expired - Fee Related
- 2000-05-03 HU HU0202379A patent/HUP0202379A3/hu unknown
-
2001
- 2001-10-30 ZA ZA200108966A patent/ZA200108966B/en unknown
- 2001-10-30 ZA ZA200108967A patent/ZA200108967B/en unknown
- 2001-11-01 IS IS6141A patent/IS6141A/is unknown
- 2001-11-02 NO NO20015374A patent/NO20015374D0/no not_active Application Discontinuation
-
2002
- 2002-06-06 HK HK02104304.1A patent/HK1042493A1/zh unknown
-
2005
- 2005-12-02 US US11/293,060 patent/US7423012B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUP0202379A2 (hu) | 2002-12-28 |
KR20020010631A (ko) | 2002-02-04 |
AR028826A1 (es) | 2003-05-28 |
MXPA01011043A (es) | 2002-06-04 |
CA2371215A1 (fr) | 2000-11-09 |
JP2002543179A (ja) | 2002-12-17 |
IL145953A0 (en) | 2002-11-10 |
IS6141A (is) | 2001-11-01 |
US20060079484A1 (en) | 2006-04-13 |
AU4447100A (en) | 2000-11-17 |
EP1180099A1 (fr) | 2002-02-20 |
PL356140A1 (en) | 2004-06-14 |
NO20015374L (no) | 2001-11-02 |
WO2000066550A1 (fr) | 2000-11-09 |
CN1358187A (zh) | 2002-07-10 |
EE200100573A (et) | 2003-02-17 |
NO20015374D0 (no) | 2001-11-02 |
US7423012B2 (en) | 2008-09-09 |
ZA200108967B (en) | 2003-01-30 |
TR200103144T2 (tr) | 2004-11-22 |
ZA200108966B (en) | 2003-01-30 |
WO2000066550A8 (fr) | 2001-01-25 |
SK15662001A3 (sk) | 2002-09-10 |
US7354895B1 (en) | 2008-04-08 |
HK1042493A1 (zh) | 2002-08-16 |
CZ20013931A3 (cs) | 2002-04-17 |
BR0010256A (pt) | 2002-02-13 |
HUP0202379A3 (en) | 2003-04-28 |
JP4270759B2 (ja) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9901573D0 (sv) | New compounds | |
RU95102778A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен | |
GEP20053673B (en) | Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents | |
AP1818A (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
SE0202462D0 (sv) | Novel use | |
GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
CY1107753T1 (el) | 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ | |
DK0920865T3 (da) | Farmaceutiske sammensætninger indeholdende norastemizol | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
SE0002476D0 (sv) | New compounds | |
SE0102440D0 (sv) | New compound | |
EP1228758A4 (fr) | Agents de prevention ou de traitement de maladies inflammatoires de l'intestin | |
SE9901572D0 (sv) | New compounds | |
DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
UY26459A1 (es) | 3,4-dihidroquinazolinas 5,6-disustituidas | |
DE60233578D1 (de) | Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung | |
SE9900190D0 (sv) | New compounds | |
TW200509915A (en) | Novel oxazoles, their manufacture and use as pharmaceutical agents | |
ATE301997T1 (de) | Antivirale therapie | |
GEP20043356B (en) | Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor | |
TW200500330A (en) | Pharmaceutical composition | |
UY27855A1 (es) | Compuestos quimicos | |
ATE270886T1 (de) | Antivirale therapie |